References
- 1PalloneJAIntroduction to Parkinson’s diseaseDis Mon20075319519910.1016/j.disamonth.2007.05.00117586325
- 2DeuschlGBainPBrinMConsensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific CommitteeMov Disord19981322310.1002/mds.8701313039827589
- 3DeuschlGRaethjenJBaronRLindemannMWilmsHKrackPThe pathophysiology of parkinsonian tremor: a reviewJ Neurol2000247V334810.1007/PL0000778111081802
- 4WenningGKBen ShlomoYMagalhaesMDanielSEQuinnNPClinical features and natural history of multiple system atrophy. An analysis of 100 casesBrain199411783584510.1093/brain/117.4.8357922469
- 5KollenspergerMGeserFNdayisabaJPet alPresentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registryMov Disord2010252604261210.1002/mds.2319220922810
- 6TisonFYekhlefFChrysostomeVet alParkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson’s diseaseMov Disord20021770170910.1002/mds.1017112210859
- 7GilmanSMaySJShultsCWet alThe North American Multiple System Atrophy Study GroupJ Neural Transm20051121687169410.1007/s00702-005-0381-616284910
- 8TadaMOnoderaOOzawaTet alEarly development of autonomic dysfunction may predict poor prognosis in patients with multiple system atrophyArch Neurol20076425626010.1001/archneur.64.2.25617296842
- 9WenningGKGeserFKrismerFet alThe natural history of multiple system atrophy: a prospective European cohort studyLancet Neurol20131226427410.1016/S1474-4422(12)70327-723391524
- 10WenningGKTisonFBen ShlomoYDanielSEQuinnNPMultiple system atrophy: a review of 203 pathologically proven casesMov Disord19971213314710.1002/mds.8701202039087971
- 11YabeISomaHTakeiAFujikiNYanagiharaTSasakiHMSA-C is the predominant clinical phenotype of MSA in Japan: analysis of 142 patients with probable MSAJ Neurol Sci200624911512110.1016/j.jns.2006.05.06416828805
- 12WakaiMKumeATakahashiAAndoTHashizumeYA study of parkinsonism in multiple system atrophy: clinical and MRI correlationActa Neurol Scand19949022523110.1111/j.1600-0404.1994.tb02712.x7839806
- 13WenningGKBen-ShlomoYMagalhaesMDanielSEQuinnNPClinicopathological study of 35 cases of multiple system atrophyJ Neurol Neurosurg Psychiatry19955816016610.1136/jnnp.58.2.1607876845
- 14GanJXie-BrustolinJGervais-BernardHValletAEBroussolleEThoboisSPossible Parkinson’s disease revealed by a pure head resting tremorJ Neurol Sci200927912112310.1016/j.jns.2008.12.02619176228
- 15GilmanSWenningGKLowPAet alSecond consensus statement on the diagnosis of multiple system atrophyNeurology20087167067610.1212/01.wnl.0000324625.00404.1518725592
- 16DejerineJJThomasAL’atrophie olivo-ponto-cérébelleuseNouvelle iconographie de la Salpêtrière190013330370
- 17LangstonWOrthostatic hypotension; report of a caseAnn Intern Med19361068869510.7326/0003-4819-10-5-688
- 18YoungRHAssociation of postural hypotension with sympathetic nervous system dysfunction; case report with review of neurologic features associated with postural hypotensionAnn Intern Med194415910916
- 19ShyGMDragerGAA neurological syndrome associated with orthostatic hypotension: a clinical-pathological studyArch Neurol1960251152710.1001/archneur.1960.0384011002500414446364
- 20AdamsRvan BogaertLvan der EeckenHDégénérescences nigro-striées et cerebello-nigro-striéesPsychiat Neurol196114221925910.1159/000131165
- 21AminoffMJWilcoxCSWoakesMMKremerMLevodopa therapy for Parkinsonism in the Shy–Drager syndromeJ Neurol Neurosurg Psychiatry19733635035310.1136/jnnp.36.3.3504714096
- 22QuinnNMultiple system atrophy – the nature of the beastJ Neurol Neurosurg Psychiatry1989Suppl788910.1136/jnnp.52.Suppl.782666581
- 23WenningGKBen-ShlomoYHughesADanielSELeesAQuinnNPWhat clinical features are most useful to distinguish definite multiple system atrophy from Parkinson’s disease?J Neurol Neurosurg Psychiatry20006843444010.1136/jnnp.68.4.43410727478
- 24RodriguezMEArtiedaJZubietaJLObesoJAReflex myoclonus in olivopontocerebellar atrophyJ Neurol Neurosurg Psychiatry19945731631910.1136/jnnp.57.3.3168158179
- 25WüllnerUSchmitz-HubschTAbeleMAntonyGBauerPEggertKFeatures of probable multiple system atrophy patients identified among 4770 patients with parkinsonism enrolled in the multicentre registry of the German Competence Network on Parkinson’s diseaseJ Neural Transm20071141161116510.1007/s00702-007-0746-017510732
- 26SongYJHuangYHallidayGMClinical correlates of similar pathologies in parkinsonian syndromesMov Disord20112649950610.1002/mds.2333621259341
- 27IodiceVLippAAhlskogJEet alAutopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function testsJ Neurol Neurosurg Psychiatry20128345345910.1136/jnnp-2011-30106822228725
- 28Gouider-KhoujaNVidailhetMBonnetAMPichonJAgidY“Pure” striatonigral degeneration and Parkinson’s disease: a comparative clinical studyMov Disord19951028829410.1002/mds.8701003107651445
- 29SalazarGValls-SoleJMartiMJChangHTolosaESPostural and action myoclonus in patients with parkinsonian type multiple system atrophyMov Disord200015778310.1002/1531-8257(200001)15:1<;77::AID-MDS1013>3.0.CO;2-N10634245
- 30KollenspergerMGeserFSeppiKet alRed flags for multiple system atrophyMov Disord2008231093109910.1002/mds.2199218442131
- 31SeppiKSchockeMFDonnemillerEet alComparison of diffusion-weighted imaging and [123I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson’s diseaseMov Disord2004191438144510.1002/mds.2022915390073
- 32OkumaYFujishimaKMiwaHMoriHMizunoYMyoclonic tremulous movements in multiple system atrophy are a form of cortical myoclonusMov Disord20052045145610.1002/mds.2034615593313
- 33AntoniniALeendersKLVontobelPet alComplementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson’s diseaseBrain19971202187219510.1093/brain/120.12.21879448574
- 34GhaemiMHilkerRRudolfJSobeskyJHeissWDDifferentiating multiple system atrophy from Parkinson’s disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imagingJ Neurol Neurosurg Psychiatry20027351752310.1136/jnnp.73.5.51712397143
- 35BrenneisCBoeschSMEggerKEet alCortical atrophy in the cerebellar variant of multiple system atrophy: a voxel-based morphometry studyMov Disord20062115916510.1002/mds.2065616161039
- 36SchwarzJTatschKGasserTet al123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonismMov Disord199813161910.1002/mds.8701301079452320
- 37WenningGKStefanovaNJellingerKAPoeweWSchlossmacherMGMultiple system atrophy: a primary oligodendrogliopathyAnn Neurol20086423924610.1002/ana.2146518825660
- 38SchragAKingsleyDPhatourosCet alClinical usefulness of magnetic resonance imaging in multiple system atrophyJ Neurol Neurosurg Psychiatry199865657110.1136/jnnp.65.1.659667563
- 39ParatiEAFetoniVGeminianiGCet alResponse to
l -DOPA in multiple system atrophyClin Neuropharmacol19931613914410.1097/00002826-199304000-000068477409 - 40AlbaneseAColosimoCBentivoglioARFeniciRMelilloGTonaliPMultiple system atrophy presenting as parkinsonism: clinical features and diagnostic criteriaJ Neurol Neurosurg Psychiatry19955914415110.1136/jnnp.59.2.1447629528
- 41GoetzCGTannerCMKlawansHLThe pharmacology of olivopontocerebellar atrophyAdv Neurol1984411431486496225
- 42LeesAJBannisterRThe use of lisuride in the treatment of multiple system atrophy with autonomic failure (Shy–Drager syndrome)J Neurol Neurosurg Psychiatry19814434735110.1136/jnnp.44.4.3477241162
- 43RajrutAHUittiRJFentonMEGeorgeDAmantadine effectiveness in multiple system atrophy and progressive supranuclear palsyParkinsonism Relat Disord1997321121410.1016/S1353-8020(97)00022-918591078
- 44MullerJWenningGKWisselJSeppiKPoeweWBotulinum toxin treatment in atypical parkinsonian disorders associated with disabling focal dystoniaJ Neurol200224930030410.1007/s00415-002-0773-611993530
- 45BotezMIBotez-MarquardTElieRLe MarecNPedrazaOLLalondeRAmantadine hydrochloride treatment in olivopontocerebellar atrophy: a long-term follow-up studyEur Neurol19994121221510.1159/00000805310343152
- 46SantensPClaeysIVonckKBoonPParkinsonism due to lamotrigineMov Disord2006212269227010.1002/mds.2112517013910
- 47TsangBKMacdonellRMultiple sclerosis – diagnosis, management and prognosisAust Fam Physician20114094895522146321
- 48WenningGKTisonFSeppiKet alDevelopment and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS)Mov Disord2004191391140210.1002/mds.2025515452868
- 49LangAELozanoADuffJet alMedial pallidotomy in late-stage Parkinson's disease and striatonigral degenerationAdv Neurol1997741992119348415
- 50Visser-VandewalleVvan der LindenCTemelYCelikHAckermansLSpincemailleGCaemaertJLong-term effects of bilateral subthalamic nucleus stimulation in advanced Parkinson disease: a four year follow-up studyParkinsonism Relat Disord200511(3)1576515823480
- 51LezcanoEGómez-EstebanJCZarranzJJet alParkinson's disease-like presentation of multiple system atrophy with poor response to STN stimulation: a clinicopathological case reportMov Disord200419973715300669
- 52SantensPVonckKDe LetterMVan DriesscheKSiebenADe ReuckJVan RoostDBoonPDeep brain stimulation of the internal pallidum in multiple system atrophyParkinsonism Relat Disord 2006 Apr12(3)1813
